Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Stefoski

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Psychotherapy and Psychosomatics|January 1, 1983
Development of somatizing responses in multiple sclerosisM Pavlou, D Stefoski
Archives of Neurology|November 1, 1988
Is steroid therapy in multiple sclerosis superior to corticotropin therapy?F A Davis, D Stefoski
Archives of Dermatology|February 1, 1983
Multiple sclerosisF A Davis, D Stefoski
Cancer|January 1, 1979
Meningiomas with conspicuous plasma cell-lymphocytic components: a report of five casesB C Horten, H Urich, D Stefoski
Annals of Neurology|February 1, 1990
Orally administered 4-aminopyridine improves clinical signs in multiple sclerosisF A Davis, D Stefoski, J Rush
Journal of the Neurological Sciences|March 1, 1977
Nonhomogeneous distribution of 5-hydroxyindoleacetic acid and homovanillic acid in the lumbar cerebrospinal fluid of manM Jakupcević, Z Lacković, D Stefoski, et al.
Annals of Neurology|May 1, 1995
Mechanism of action of 4-aminopyridine in the symptomatic treatment of multiple sclerosisF A Davis, D Stefoski, F N Quandt
Annals of Neurology|October 1, 1985
Acute improvement in exacerbating multiple sclerosis produced by intravenous administration of mannitolD Stefoski, F A Davis, C L Schauf
Annals of Neurology|January 1, 1987
4-Aminopyridine improves clinical signs in multiple sclerosisD Stefoski, F A Davis, M Faut, et al.
Journal of Clinical Apheresis|January 1, 1983
Partial plasma protein replacement in therapeutic plasma exchangeB C McLeod, R J Sassetti, D Stefoski, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Psychotherapy and Psychosomatics|January 1, 1983
Development of somatizing responses in multiple sclerosisM Pavlou, D Stefoski
Archives of Neurology|November 1, 1988
Is steroid therapy in multiple sclerosis superior to corticotropin therapy?F A Davis, D Stefoski
Archives of Dermatology|February 1, 1983
Multiple sclerosisF A Davis, D Stefoski
Cancer|January 1, 1979
Meningiomas with conspicuous plasma cell-lymphocytic components: a report of five casesB C Horten, H Urich, D Stefoski
Annals of Neurology|February 1, 1990
Orally administered 4-aminopyridine improves clinical signs in multiple sclerosisF A Davis, D Stefoski, J Rush
Journal of the Neurological Sciences|March 1, 1977
Nonhomogeneous distribution of 5-hydroxyindoleacetic acid and homovanillic acid in the lumbar cerebrospinal fluid of manM Jakupcević, Z Lacković, D Stefoski, et al.
Annals of Neurology|May 1, 1995
Mechanism of action of 4-aminopyridine in the symptomatic treatment of multiple sclerosisF A Davis, D Stefoski, F N Quandt
Annals of Neurology|October 1, 1985
Acute improvement in exacerbating multiple sclerosis produced by intravenous administration of mannitolD Stefoski, F A Davis, C L Schauf
Annals of Neurology|January 1, 1987
4-Aminopyridine improves clinical signs in multiple sclerosisD Stefoski, F A Davis, M Faut, et al.
Journal of Clinical Apheresis|January 1, 1983
Partial plasma protein replacement in therapeutic plasma exchangeB C McLeod, R J Sassetti, D Stefoski, et al.
Pageof 3